Research grant utilizing PLCO bioresources for advancing cancer etiology and early detection biomarkers through biochemical and genetic analyses.
NCI supports research on how biospecimen collection, processing, and storage affect biomarkers, aiming to standardize handling and improve clinical assay development; clinical trials are not allowed.
Supports multidisciplinary research teams developing and validating biomarkers for early pancreatic cancer detection and identifying high-risk patients and precursor lesions likely to progress to cancer.
This grant supports planning of cancer prevention and control clinical trials to enhance trial design, feasibility, and reduce costs for effective cancer interventions.
This grant supports researchers in analyzing existing data to understand cancer risk and related outcomes, aiming to address key scientific questions in cancer research.
Facilitates well-planned cancer prevention and control clinical trials by addressing information gaps to improve trial design and feasibility, saving time and money for NCI.